MS in the News includes: Updates on Stem Cell therapy, CCSVI, Research and more

Stu's Views and MS News

Today is February 4, 2010

This newsletter is now reaching (66) Countries

This week's edition includes:

ORAL Medications, Research, Pediatric MS,

Stem Cell and CCSVI Updates,

Benefits vs Risks for Tysabri,

Mobility in the workplace and more

#####################################

If you have information you want others to see, relating to Multiple Sclerosis,

please send the information to me for posting to the blog and to be seen in an

upcoming e-newsletter. - thank you

#####################################

This week's Postings:

• While In Rome- do as the Romans do" - -
• Oral Cladribine for Relapsing Multiple Sclerosis -... Oral
• AMPYRA for MS: Acorda Therapeutics Provides patient... - Oral
• Reflexology and Multiple Sclerosis
• Could Teeth Brushing Impact MS?
• MS related: Stem cell research and its ethical con...
• Mobility in the workplace
• Mothers with MS Adapt to Parenting with Fatigue
• I Still Dream Big: Stories of Teens Living with Ch...
• Multiple Sclerosis risk, changes with the seasons
• Could stem cells reverse MS?
• Benefits of Tysabri far outweigh risks, European w...
• Biologist launches stem cell test to cure Multiple...
• Italian group offers $4.5M to fund new MS research... - CCSVI

#####################################

e-Newsletter Disclaimer:

***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

.